The skin, fin and bone of Bester sturgeon were successively soaked in 1% NaCl solution at 4 
Preparation of A-SCP 3
Atelocollagen peptides (A-SCP) were prepared as follows. The skin of Bester sturgeon was 4 cut into small pieces. The pieces were successively soaked in 5% H 2 
Animals 17
Six weeks old male ICR mice were purchased from Charles River Laboratories (Yokohama, 18 Japan). They were maintained under controlled temperature (23±1 o C), humidity (50±10%), 19 and 12 h-light/dark cycle (light: 8:00 ~ 20:00) with free access to deionized water and MF 20 diet (Oriental Yeast Co., Tokyo, Japan). All procedure for the use and care of the mice were 21 approved by Institutional Animal Care and Use Committee of National University 22
Corporation Hokkaido University. 23 24
Measurement of blood glucose levels in mice

７
All the oral glucose tolerance tests (OGTT) were performed as follows. ICR mice were fasted 1 for 16 h and performed an OGTT. The mice were divided into a control group and sample 2 groups (SCP, BSA hydrolysate, the f1, f2, f3 or A-SCP) matched for body weight in each test. 3
After basal blood collection (0 min), glucose solution (2 g/kg body weight, 15 mL/kg body 4 weight) mixed with sample (1.5 g/kg body weight) (sample group) or with distilled water 5 (control group) were orally injected with a disposable probe (FUCHIGAMI, Kyoto, Japan). A 6 single drop of blood was periodically sampled (15, 30, 60 and 120 min after injection) from 7 tail vein and glucose levels were measured using a glucose sensor (GLUCOCARD MyDIA, 8 ARKRAY Inc., Kyoto, Japan). Area under the glucose curves between 0 and 120 min (AUC) 9
were calculated by the trapezoidal rule based on the blood glucose levels up to the time of 10 final measurement for each group. 11 12 2.5. Gel filtration 13 SCP was fractionated by gel filtration on Sephadex G-50 and Sephadex G-25 (GE Healthcare 14 Bio-Science AB, Uppsala, Sweden). Both columns (G-50: 4.0 x 77 cm, G-25: 6.5 x 100 cm) 15 were equilibrated with distilled water, and peptides were eluted with the same solution at a 16 flow rate of 0.7 mL/min and detected by the absorbance at 230 nm. 17 18
Reversed-phase HPLC 19
The samples were dissolved to a final concentration of 0.5 mg/mL in ultrapure water 20 containing 0.1% trifluoroacetic acid (TFA). The solutions applied to filtration by Peptides in the filtrate were separated by reversed-phase HPLC with a Mightysil RP-18 GP 22
Aqua (4.6 x 250 mm) (KANTO CHEMICAL CO., INC., Tokyo, Japan). Elution was 23 performed with a linear gradient of acetonitrile from 5 to 80% in 0.1% TFA at a flow rate of 24 1.0 mL/min. SDS-PAGE was performed on a 0.1% SDS-7.5% polyacrylamide slab-gel according to the 7 method of Laemmli (Laemmli, 1970) . The atelocollagen was dissolved in 0.1 M HCl (3 mg 8 atelocollagen / mL) and centrifuged at 4 o C, 15,000g for 5 min. The supernatant was mixed at 9 a ratio of 1:1 (v/v) with the sample buffer (0.0625 M Tris-HCl buffer (pH 6.8), 4% SDS, 20% 10 glycerol, 10% 2-mercaptoethanol and 2% bromophenol blue as the dye) and boiled for 5 min. 11
Ten milligrams of protein were loaded in each lane. Electrophoresis was carried out at 10 mA. 12
After electrophoresis, the gel was stained with 0.1% Coomassie Brilliant Blue R-250 in 50% 13 methanol-7% acetic acid, and then destained in 7% acetic acid. Protein Molecular Weight 14 Markers (GE Healthcare Life Sciences, Tokyo, Japan) were used to estimate the molecular 15 weight. 16
The triple helical structure of the prepared atelocollagen was validated with reference 17 to the denaturation temperature of Bester sturgeon collagen (Zhang et al., 2014) 
Statistical analysis 24
The data of OGTT were expressed as mean ± standard error of the mean (SEM 
Preparation of SCP 7
We obtained 85.1 g (dry weight) of SCP from 864 g (wet weight) of the skin, fin and bone of 8
Bester sturgeon (yield: approximately 100 g SCP/kg by-products). As the papain hydrolysates 9 contained a small amount of lipid (mainly triglyceride), we removed them by ethanol 10 treatment because the lipids cause fish odor and oxidation that lead quality degradation. The 11 final of SCP was white, odorless, and easily soluble in water by the treatment. 12 13
Hypoglycemic effect of SCP 14
Blood glucose levels rapidly increased after glucose injection to 15 min in all the groups (Fig.  15   1a ). In the control group, the levels kept increasing to 247 mg/dL at 30 min, and then returned 16 to the basal level at 120 min. However, in the SCP group, the levels slightly increased to 198 17 mg/dL at 30 min, and gradually declined to the basal level. The level was significantly lower 18 than that of the control group at 15 min. In the BSA hydrolysate group, the levels also 19 increased to 210 mg/dL at 15min, and then turned to decrease differing from the control and 20 SCP groups. Although the levels were lower than those of the control group at 15 and 30 min, 21 the levels did not go below those of the SCP group. The AUCs of the SCP and BSA 22 hydrolysate groups were lower than that of the control group. However, there was no 23 difference in the AUCs among all the groups (Fig. 1b) . 24 １０
Investigation of the relationship between hypoglycemic effect of SCP and its structure 1
Using gel filtration with Sephadex G-50, we obtained a single fraction as F1 (Fig. 2a) . Thus, 2 we fractionated F1 with Sephadex G-25 and detected three fractions; f1, f2 and f3 (Fig. 2b) . 3
In OGTT, the F1 group lowered blood glucose levels (The data was not shown). All the three 4 fractions showed hypoglycemic effect, and the levels of the f2 and f3 groups were 5 significantly lower than those of the control group at 15 and 30 min (Fig. 3a) . Also, the levels 6 of the f1 and f2 groups were significantly lower than those of the control group at 30 and 60 7 min. The AUCs of the f1 and f2 groups were also significantly lower than that of the control 8 group, and there was no difference in the AUCs between the f1 and f2 groups (Fig. 3b) . 9
Furthermore, we performed reverse-phased HPLC analysis and clarified amino acid 10 sequences of the peptides in the three fractions. In the analysis, we obtained 6 peptide 11 sequences from the f1 fraction, 5 peptide sequences from the f2 fraction, and 7 peptide 12 sequences from the f3 fraction, respectively (Fig. 4a, 4b and 4c ). As shown in Table 1 
Structure of A-SCP 21
We prepared an atelocollagen from the skin of Bester sturgeon. As shown in Fig. 5a , the 22 prepared atelocollagen consisted of the β-chain (ca. 220kDa) which was formed by 23 intramolecularly cross-linking between two α-chains, the α1-chain (ca. 120kDa) and the 24 α2-chain (ca. 110kDa), and the density of the α1-chain band was higher than that of the１１ α2-chain band. This result suggests the atelocollagen seems to be classified as type I collagen. 1
In Fig. 5b , although the density of the bands of the β-chain and α-chains were clearly 2 observed in the undigested atelocollagen, the band intensity became lower at 15 o C and lots of 3 bands were observed in low molecular weight. It means that part of the prepared atelocollagen 4 is denatured and digested by pepsin at 15 o C. Moreover, the bands of the chains were 5 completely abolished by pepsin digestion at 35 o C. These results affirm previous study (Zhang 6 et al., 2014) , and demonstrate the prepared atelocollagen formed a triple helix structure. 7 8
Changes in blood glucose levels under A-SCP administration in OGTT 9
Blood glucose levels increased to 30 min in all the groups (Fig. 6a) . The levels of the A-SCP 10 group were slightly higher than those of the SCP group and peaked to 301 mg/dL. The levels 11 of the A-SCP group were significantly lower than those of the control group at 15, 30 and 60 12 min, similarly to those of the SCP group. There was no difference in the blood glucose levels 13 between the A-SCP and SCP groups. The AUC of the A-SCP group was also significantly 14 lower than that of the control group, similarly to that of the SCP group (Fig. 6b) . 15 16
Discussion 17
We obtained approximately 100 g SCP/kg by-products; the skin, fin and bone of Bester 18 sturgeon. The yield of SCP (9.8%) was similar to that of collagen (11.9% on a wet weight 19 basis) prepared from the skin of Bester sturgeon in previous study (Zhang et al., 2014) . 20
Moreover, SCP had the physical properties, e.g., white, odorless, and easily soluble in water, 21
and it could be advantage in use SCP as an ingredient for functional foods. 22
First, we examined the hypoglycemic effects of SCP in normal mice. In OGTT, SCP 23 significantly decreased blood glucose levels as compared with those of the control group (Fig.  24   1a) . The BSA hydrolysate also decreased blood glucose levels. BSA is one of the major 25 １２ protein contained in whey which has the potential to improve glycemic control (Frid, Nilsson, 1 Holst, & Björck, 2005; Gillespie, Calderwood, Hobson, & Green, 2015; Nilsson, Stenberg, 2 Frid, Holst, & Björck, 2004; Schopen et al., 2017) . Besides, long-term intake of BSA 3 improved fasting insulin and glucose in mice even though the mice were fed high fat diet 4 (McManus et al., 2015) . Thus, in this study, the BSA hydrolysate might enhance insulin 5 secretion. 6
In previous study, we confirmed that a matter of lipid (0.38% on a dry weight basis 7 of SCP) existed in SCP (data not shown). By thin-layer chromatography (TLC) analysis, the 8 lipid was mainly composed of triglyceride and contained little free fatty acid and sterol. 9
Furthermore, we removed the residual lipid from SCP by supercritical fluid extraction (SFC) 10 using carbon dioxide, and then no triglyceride, free fatty acid and sterol were detected in the 11 SFC-treated SCP by TLC. In OGTT with normal ICR mice, blood glucose levels also 12 decreased in the SFC-treated SCP group as well as in the SCP group. Therefore, we 13 demonstrated that the peptides in SCP affect hyperglycemia, not the residual lipid in SCP. 14 Next, we fractionated SCP with gel filtration to discuss its structure-function 15 relationship. Using gel filtration with Sephadex G-25, we obtained three fractions (Fig. 2b) . In 16 OGTT, although all the three fractions showed hypoglycemic effect, the f1 and f2 groups 17 showed higher effect than the f3 group (Fig. 3a and Fig. 3b ). However, there was no 18 correlation between the potency and the mean molecular weights of the fractions. Therefore, 19 we considered that the hypoglycemic effect was occurred by not the molecular weight but the 20 structure of the peptides in the fractions. With analysis of amino acid sequence, the f1 and f2 21 fractions possessed the Gly-X-Y repetitive sequences, while the f3 fraction contained both the 22 repetitive and non-repetitive sequences (Table 1) . These results suggest that the peptides in the 23 f1 and f2 fractions are derived from the triple helix region of the collagen molecules, and the 24 peptides in the f3 fraction are derived from both the triple helix region and the non-helical１３ region known as the telopeptide region which does not contain the Gly-X-Y repetitive 1 sequence. For instance, f3-6 in Table 1 comes from the N-terminal telopeptide of type 1 2 sturgeon collagen α1-chain (DNA Data Bank of Japan accession number EU241879, 3 LC008481-8485). Therefore, the f3 fraction most likely contains the Gly-X-Y repetitive 4 sequences relatively less than the f1 and f2 fractions per unit weight. Because it seemed that 5 the existence of the Gly-X-Y repetitive sequences related to the potency of the fractions (Fig.  6 3a and 3b), we hypothesized that the Gly-X-Y repetitive sequences which were derived from 7 the triple helix region bring the hypoglycemic effect. To verify the hypothesis, we prepared 8 A-SCP from the atelocollagen, which only consist of the Gly-X-Y sequences and form the 9 triple helical structure, and evaluated its hypoglycemic effect. As shown in Fig. 6a and Fig. 6b,  10 A-SCP indicated equivalent hypoglycemic ability to that of SCP. This result clearly shows 11 that the effective peptides derived from the Gly-X-Y repetitive sequences, namely the triple 12 helix region of the collagen molecule has the hypoglycemic effect. Li-Chan et al. (2012) 13 reported that two kinds of peptides including Gly-X-Y sequences showed hypoglycemic 14 effect (Li-Chan, Hunag, Jao, Ho, & Hsu, 2012) . Our finding is consistent with the report of 15 Li-Chan et al. (2012) . The peptides in the f1 and f2 fractions formed oligo-peptides which 16 differs from the peptides reported by Li-Chan et al. (2012) . Several studies reported that 17 collagen peptides administrated orally digested into di-and/or tri-peptides and absorbed into 18 the blood (Iwai et al., 2005; Ohara, Matsumoto, Ito, Iwai, & Sato, 2007; Shigemura, 19 Kubomura, Sato, & Sato, 2014) . For this reason, SCP is more likely to affect after digestion 20 into di-/tri-peptides in gastrointestinal tract. 21
In hypoglycemic studies, DPP-IV is well known as an enzyme inactivating incretin 22 hormone which stimulate insulin secretion; glucose-dependent insulinotropic polypeptide 23 (GIP) and glucagon-like peptide-1 (GLP-1). Several food-derived peptides are reported to 24 exert hypoglycemic effect via DPP-IV inhibition and GLP-1 secretion (Higuchi, Hira, Yamada,１４ & Hara, 2013; Ishikawa et al., 2015; Mochida et al., 2010) . DPP-IV inhibition is also 1 observed in collagen peptides, and it is expected that the inhibition effect is attributed to Pro 2 rich structure of collagen peptides because DPP-IV degrades peptides with Pro and Ala in the 3 penultimate N-terminal residues (Hsieh et al., 2015; Iba et al., 2016; Li-Chan et al., 2012; 4 Mentlein, Gallwitz, & Schmidt, 1993) . There are many peptides containing Pro and Ala 5 residues in SCP, and thus SCP might show DPP-IV inhibitory activity. Now, we are studying 6 the detail mechanisms of the hypoglycemic effect by SCP. 7 8
Conclusion
9
Collagen peptides (SCP), which were white, odorless and water-soluble, were prepared from 10
Bester sturgeon by-products: skin, fin and bone. In OGTT with normal mice, SCP 11 significantly improved glucose tolerance. The result implies that SCP has a potential as a 12 beneficial ingredient for functional foods preventing type 2 diabetes mellitus. Moreover, it is 13 suggested that the hypoglycemic effect of SCP might be caused by the peptides which possess 14 structural properties of the Gly-X-Y repetitive sequence and/or an abundance of Pro and Ala 15 residues derived from the triple helical region of the collagen molecule. 16 17 Figs.2
